Efficacy of AdiDetox™ in reducing the toxicity of fumonisin B1 in rats

Food Chem Toxicol. 2015 Apr:78:60-3. doi: 10.1016/j.fct.2015.01.024. Epub 2015 Feb 4.

Abstract

The objective of this study is to evaluate the efficacy of a new mycotoxin inactivator (AdiDetox™) in reducing the toxic effects of fumonisin B1 (FB1) in the diet of rats. Sixty-four male Sprague-Dawley growing rats (125 g ± 1 g BW) were assigned to eight dietary treatments for seven days. The experiment had a 2 × 4 factorial arrangement with two levels of FB1 (0 mg and 15 mg of FB1/kg feed) and four levels of AdiDetox™ (0 g, 1 g, 2 g and 5 g /kg feed) in the diet. No significant differences were observed in the growth performance among treatments (P > 0.05), though low levels of sphingosine (So) and sphinganine (Sa) were detected in the liver. However, So and Sa and the Sa/So ratio in kidneys were higher in rats receiving the FB1 diets (P < 0.0001) than in those fed the Control diet. Supplementation of AdiDetox™ to the diet significantly reduced the toxic effects of FB1, leading to a significant decrease in the Sa content and in the Sa/So ratio in kidneys. In conclusion, the results suggest that AdiDetox™ can effectively reduce toxicity of FB1 in growing rats.

Keywords: Adsorbent; Fumonisin B(1); Toxicity and rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Fumonisins / toxicity*
  • Kidney / drug effects
  • Kidney / metabolism
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Organ Size / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Sequestering Agents / pharmacology*
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Triglycerides / blood
  • Uric Acid / blood

Substances

  • Fumonisins
  • Sequestering Agents
  • Triglycerides
  • Uric Acid
  • fumonisin B1
  • Aspartate Aminotransferases
  • Alkaline Phosphatase
  • Sphingosine
  • safingol